PlainRecalls
FDA Drug Critical Class I Terminated

8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx Only, Mfd for: Civica, Inc. Lehi, Utah 84043, Mfd by: Exela Pharma Sciences, LLC, Lenoir, NC 28645, Carton NDC 72572-740-20, vial NDC 72572-740-1.

Reported: November 2, 2022 Initiated: October 4, 2022 #D-0023-2023

Product Description

8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx Only, Mfd for: Civica, Inc. Lehi, Utah 84043, Mfd by: Exela Pharma Sciences, LLC, Lenoir, NC 28645, Carton NDC 72572-740-20, vial NDC 72572-740-1.

Reason for Recall

Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration

Details

Recalling Firm
Exela Pharma Sciences LLC
Units Affected
148,920
Distribution
Nationwide within the United States
Location
Lenoir, NC

Frequently Asked Questions

What product was recalled?
8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx Only, Mfd for: Civica, Inc. Lehi, Utah 84043, Mfd by: Exela Pharma Sciences, LLC, Lenoir, NC 28645, Carton NDC 72572-740-20, vial NDC 72572-740-1.. Recalled by Exela Pharma Sciences LLC. Units affected: 148,920.
Why was this product recalled?
Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration
Which agency issued this recall?
This recall was issued by the FDA Drug on November 2, 2022. Severity: Critical. Recall number: D-0023-2023.